ライフサイエンスコーパス: S.D.

1 (S.D.+/-0.7) in the 15 to 24 age group; 3.0 (S.D.+/-1.5) in the 45 to 54 age group; and 3.02 (S.D.+/-

2 +/-1.5) in the 45 to 54 age group; and 3.02 (S.D.+/-1.4) in the 75 to 94 age group.

3 eriod of 12 months was approximately 1.4% (1 S.D., n = 26), respectively.

4 le crude oil reference material NIST 8505 (1 S.D., n = 6).

5 to 93 years with a meanof 69.5 years +/- 7.1(S.D.).

6 he scaling exponents (from 0.73 +/- 0.11 (+/-S.D., session 1), 0.72 +/- 0.10 (session 2) and 0.75 +/-

7 cytes ( approximately 4,000 +/- 5,600 (+/- 2 S.D.) copies/cell).

8 Values for compromised fetuses were -2 S.D. from a group of control (n = 14) fetuses.

9 were between 15 to 94 years (mean age: 47.2, S.D.+/-15.2).

10 Cisplatin was 2.6 +/- 0.3- (S.D.), 3.6 +/- 0.9-, and 2.3 +/- 0.1-fold more potent at

11 ons, and each one contains an average of 34 (S.D. +/- 13) myelinated axons.

12 ight-handed men (mean age 30.5, range 18-37, S.D. 6.5 years) given the same olfactory nerve stimuli i

13 women (mean age 25.3 years old, range 20-44, S.D. 8.3 years) were compared with those of 8 right-hand

14 uated increase in HR (7 +/- 4% vs. 13 +/- 7% S.D.), CO (10 +/- 6% vs. 18 +/- 8%) and femoral blood fl

15 NA increased from supine to upright (17+/-8 (S.D.) versus 38+/-12 bursts min-1; P<0.01), and continue

16 ion that occurs on deoxygenation (from 0.82 (S.D., 0.07) to 1.40 mm (S.D., 0.17)).

17 metabolism) in 11 old (71 +/- 9 years of age S.D.) and 11 young (24 +/- 2 years of age) healthy subje

18 normotensive Caucasian adults (mean age (+/- S.D.) = 29 +/- 6 years), who were either Arg16 (n = 18)

19 il 27-28, 2006, organized by D.W. Gilroy and S.D. Brain for the British Pharmacology Society.

20 il 27-28, 2006, organized by D.W. Gilroy and S.D. Brain for the British Pharmacology Society.

21 .5 ata had better mean+/-standard deviation (S.D.) behavioral scores (14+/-2; p<0.05) than control (1

22 The standard deviation (S.D.) for the time difference between the peaks of sJPs

23 h more variable beat-to-beat intervals (mean S.D. of beat-to-beat intervals was 0.027 s/beat in contr

24 Mean (+/-S.D.) values for T0.20, T0.50, T0.95 were: 39.6+/-7.2, 5

25 In group I, mean (+/-S.D.) value for CSF production was 51+/-10 microliter/mi

26 hot plate test (52 degrees C): the mean (+/-S.D.) hind paw lick latency of rats in the high anti-NGF

27 he intracellular pH, 7.54 +/- 0.03 (mean +/- S.D., n = 15), determined with the Neutral red method, o

28 engths s-1): type I, 0.54 +/- 0.05 (mean +/- S.D., n = 3); type IIA, 1.23 +/- 0.34 (n = 27); type alp

29 .1 +/- 0.31 and 2.3 +/- 0.18 m s-1 (mean +/- S.D.) at 23 degrees C.

30 to (1.65 +/- 0.60) x 10(-6) cm s-1 (mean +/- S.D.) within 20-60 min.

31 trimethaphan, 4.4 +/- 1.1 mg min-1 (mean +/- S.D.)).

32 ea expansion was 490 +/- 88 mN m-1 (mean +/- S.D.).

33 x)) was 16 871 +/- 2941 mmHg s(-1) (mean +/- S.D.) and the relaxation time constant was 3.9 +/- 0.8 m

34 estimated to be 13 +/- 10 m s(-1) (mean +/- S.D., n = 12 subjects).

35 d a PCr/NTP ratio of 0.93 +/- 0.11 (mean +/- S.D.) using a 2 s interpulse interval, a value very clos

36 ns) (neurobehavior index 43 +/- 19, mean +/- S.D.) compared to Group 1 rats, in which only spontaneou

37 out 1) and 40.7 +/- 8.4 s (bout 2) (mean +/- S.D.) and (b) the magnitude of the later slow component

38 ifferentiation by 87 +/- 7% (n = 2, mean +/- S.D.) but had no effect on 1,25-(OH)2D3 inhibition of ce

39 ticulum (ER) (pH(ER) = 7.4 +/- 0.2, mean +/- S.D.) to Golgi (pH(G) = 6.2 +/- 0.4) to mature secretory

40 cells (HUVEC) by 111% (111 +/- 21%, mean +/- S.D.) and 93% (93 +/- 17%), respectively.

41 intrinsic stiffness is 91 +/- 23 % (mean +/- S.D.) of that necessary to provide minimal stabilisation

42 mate concentrations (0.65 +/- 0.23; mean +/- S.D.) and varies with agonist concentrations.

43 S.D./mean) averaged 1.65 +/- 0.26% (mean +/- S.D., n = 9).

44 , 32, and 24b was 51,603 +/- 3,324 (mean +/- S.D.; n = 8).

45 osages and times was 52.4 +/- 81.4 (mean +/- S.D.) s.

46 both breath amplitude (152 +/- 73%; mean +/- S.D.; P = 0.004) and frequency (46 +/- 37%; P = 0.049).

47 lderly subjects were studied with a mean +/- S.D. age and body mass index (BMI) of 71 +/- 5 years and

48 anged from 93 to 285 microV, with a mean +/- S.D. of 172 +/- 47 microV.

49 ression of fiber volley amplitudes (mean +/- S.D.; p < 0.001 ANOVA, n = 10).

50 4.8 kg and height 163.4 +/- 9.1 cm, mean +/- S.D.) and control (n = 9; age 67.1 +/- 2 years, body mas

51 ) was 138 ppqv (140 +/- 29 ppqv for mean +/- S.D.) during the June 2011 study period.

52 CAO; 31 +/- 3.7 mm3 1 h after MCAO (mean +/- S.D.) when administered intracranially up to 60 min post

53 rd resting levels by 20 +/- 15 min (mean +/- S.D.) post-transection, except in regions of the axon wi

54 80 % complete at 13.5 +/- 3.0 min (mean +/- S.D.; n = 7) after adapting light offset.

55 aseline [Na+]i was 14.6 +/- 4.9 mM (mean +/- S.D.) in CO2/HCO3(-)-containing saline with 3 mM K+.

56 baseline [Na+]i of 8.9 +/- 3.8 mM (mean +/- S.D.).

57 tentials ranged from -49 to -40 mV (mean +/- S.D. -44.0 +/- 4.3 mV).

58 ecording, E(GABA) was -25 +/- 5 mV (mean +/- S.D.), and was stable between embryonic day 17 and post-

59 tentials averaged 0.33 +/- 0.04 mV (mean +/- S.D., n = 6).

60 ansient magnitude of 318 +/- 28 nm (mean +/- S.D., n = 12).

61 nstant, tau fast, of 0.9 +/- 0.2 s (mean +/- S.D.) and a later, slow time constant, tau slow, of 4.2

62 ase (p < 0.05) in diabetic samples (mean +/- S.D., 313.8 +/- 52.7 pmol/mg protein) when compared with

63 The enhancement was (mean +/- S.D.) 7.7 +/- 5% to 192 +/- 52% upon coapplication of 3

64 male subjects (age 29 +/- 7 years, mean +/- S.D.) performed three transitions to a work rate (WR) co

65 ive subjects (age, 40 +/- 10 years: mean +/- S.D.), orthostatic tolerance was assessed using graded l

66 ated 3.9+/-1.7 mm and 6.1+/-3.4 mm2 (mean +/-S.D.) of linear bone height and bone area, respectively.

67 und after versus before activation (mean =/- S.D.; n = 3) was: for AP7.3, 9.8 =/- 0.6; for PAC1.1, 8.

68 veloped larger infarcts (40.1+/-1.0%, mean+/-S.D., p<0.001) than MS- or aCSF-treated controls (34.3+/

69 infarct volume of 178.7+/-84.2 mm(3) (mean+/-S.D.) with a large coefficient of variation (47%) and ra

70 (178.7+/-84.2 vs. 243.3+/-50.1 mm(3), mean+/-S.D., Student's t-test P=0.046) and showed a greater var

71 scular profiles occupied 4.3+/-0.36% (mean+/-S.D.) of the microscopic field.

72 n CBF of the SHR (1.5+/-0.2 ml/g/min, mean+/-S.D.) was approximately 25% higher than that of the WKY

73 Similarly, total infarct volumes (mean+/-S.D.) were smaller in animals receiving HBO at 2.5 ata (

74 ntrol subjects aged 15.2+/-0.5 years (mean+/-S.D.) and eighteen IA subjects aged 15.1+/-1.4 years wer

75 nd 0.1 +/- 0.2 Hz after carbachol (means +/- S.D.)).

76 haemorrhage for 18.0 +/- 4.6 days (means +/- S.D.) during which time the haematocrit was reduced from

77 11 nmol of ferriprotoporphyrin IX (means +/- S.D. for four experiments).

78 eter of 1.6 microm (range = 0.11-7.4 microm, S.D. = 1.01, n = 311) with a small percentage (8%) being

79 0.79 of resting fluorescence and 0.8 micron (S.D., 0.17 and 0.2 micron; n = 193), respectively.

80 ed seizure latency from about 17+/-8 min (+/-S.D.) in controls to 5+/-1 and 6+/-2 min, respectively.

81 The mean distance CEJ-bone level was 1.4 mm (S.D.+/-0.7) in the 15 to 24 age group; 3.0 (S.D.+/-1.5)

82 genation (from 0.82 (S.D., 0.07) to 1.40 mm (S.D., 0.17)).

83 For a set of more than 500 samples an R.S.D. of less than 10% was achieved.

84 Intra-day and inter-day precision (% R.S.D.) of the developed method was less than 4% while % a

85 for over 92% of compounds, and precision (R.S.D.%) always lower than 12%.

86 trated to be highly reproducible since the R.S.D. for 10 successive amperometric calibrations using t

87 for Cu, Fe, Ni and Zn, respectively, with R.S.D. ranging from 1.4% to 3.6%.

88 averaging: tauV(O(2))(,on) 35 +/- 14 s (+/- S.D.), tau[PCr](on) 33 +/- 12 s, tauV(O(2))(,off) 50 +/-

89 )); i.e. tau(1,on) averaged 33 +/- 16 s (+/- S.D.) and tau(1,off) 29 +/- 6 s.

90 racellular patches was 323.5 +/- 146.2 s (+/-S.D., n = 20 WPBs).

91 owing WPB exocytosis was 2.98 +/- 1.88 s (+/-S.D., n = 32 WPBs).

92 On average they had 24.8 teeth (S.D.+/-5.5).

93 The S.D. for large amplitude JPs (approximately 30 ms), whic

94 The relative spread (RS) of thresholds (S.D./mean) averaged 1.65 +/- 0.26% (mean +/- S.D., n = 9

95 - 8 dendritic profiles (group mean value +/- S.D., five animals), whereas clusters in layer 2 contain